These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2126146)

  • 41. Treatment of chronic hepatitis B, delta related liver disease and non-A non-B hepatitis.
    Jafri SM
    J Pak Med Assoc; 1989 Jun; 39(6):162-7. PubMed ID: 2475648
    [No Abstract]   [Full Text] [Related]  

  • 42. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic viral hepatitis: when interferon does not work].
    Costa C; Rizzetto M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):127-31. PubMed ID: 7542484
    [No Abstract]   [Full Text] [Related]  

  • 45. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: interim results of a randomized controlled open study.
    Weiland O; Schvarcz R; Wejstål R; Norkrans G; Foberg U; Frydén A
    Scand J Infect Dis; 1989; 21(2):127-32. PubMed ID: 2499037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current topics in viral hepatitis.
    Padilla VM; Schiff ER
    Compr Ther; 1991 Sep; 17(9):7-12. PubMed ID: 1722743
    [No Abstract]   [Full Text] [Related]  

  • 48. Interferon treatment for hepatitis.
    Schattner A; Revel M
    Isr J Med Sci; 1989 Jul; 25(7):357-9. PubMed ID: 2474520
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of chronic viral hepatitis.
    Dusheiko GM; Zuckerman AJ
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():107-20. PubMed ID: 8407692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up of antiviral combination therapy in chronic hepatitis B.
    De Man RA; Schalm SW; Heijtink RA; Berk L; Den Ouden J; ten Kate FJ; Chamuleau RA; Reesink HW
    Am J Med; 1988 Aug; 85(2A):150-4. PubMed ID: 3044080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.
    Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E
    Am J Gastroenterol; 1990 Jan; 85(1):24-9. PubMed ID: 1688684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of interferon-alpha in virus infections.
    Finter NB; Chapman S; Dowd P; Johnston JM; Manna V; Sarantis N; Sheron N; Scott G; Phua S; Tatum PB
    Drugs; 1991 Nov; 42(5):749-65. PubMed ID: 1723372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon treatment of chronic non-A, non-B (HCV) hepatitis: the saga continues.
    Koff RS
    Gastroenterology; 1990 May; 98(5 Pt 1):1384-6. PubMed ID: 2108893
    [No Abstract]   [Full Text] [Related]  

  • 55. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 56. [Report on interferon treatment in chronic hepatitis. Office of the General Deputy Director of Benefits and Evaluation of Health Technologies. Office of the General Director of Insurance and Health Planning].
    Gastroenterol Hepatol; 1995 Jan; 18(1):33-41. PubMed ID: 7542554
    [No Abstract]   [Full Text] [Related]  

  • 57. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
    J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.
    Berk L; de Man RA; Housset C; Berthelot P; Schalm SW
    Prog Clin Biol Res; 1991; 364():411-20. PubMed ID: 2020718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.